Cargando…
Cost-effectiveness of bivalent versus monovalent vaccines against hand, foot and mouth disease
OBJECTIVES: Enterovirus 71 (EV71) and coxsackievirus A16 (CA16) were responsible for 43.3% (235 123/543 243) and 24.8% (134 607/543 243) of all laboratory-confirmed hand, foot and mouth disease (HFMD) cases during 2010–2015 in China. Three monovalent EV71 vaccines have been licensed in China while b...
Autores principales: | Liu, D., Leung, K., Jit, M., Yu, H., Yang, J., Liao, Q., Liu, F., Zheng, Y., Wu, J.T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942242/ https://www.ncbi.nlm.nih.gov/pubmed/31279839 http://dx.doi.org/10.1016/j.cmi.2019.06.029 |
Ejemplares similares
-
From Monovalent to Multivalent Vaccines, the Exploration for Potential Preventive Strategies Against Hand, Foot, and Mouth Disease (HFMD)
por: He, Xiangchuan, et al.
Publicado: (2020) -
Economic costs and health-related quality of life for hand, foot and mouth disease (HFMD) patients in China
por: Zheng, Yaming, et al.
Publicado: (2017) -
Effect of monovalent and bivalent live attenuated vaccines against QX-like IBV infection in young chickens
por: Yang, Chen-Yu, et al.
Publicado: (2023) -
Immunogenicity and Protection against Foot-and-Mouth Disease Virus in Swine Intradermally Vaccinated with a Bivalent Vaccine of Foot-and-Mouth Disease Virus Type O and A
por: Kim, Dong-Wan, et al.
Publicado: (2023) -
Comparative Effectiveness of COVID-19 Bivalent Versus Monovalent mRNA Vaccines in the Early Stage of Bivalent Vaccination in Korea: October 2022 to January 2023
por: Kim, Ryu Kyung, et al.
Publicado: (2023)